Visualitza per autor "Sablin, Marie-Paule"
Ara mostrant els elements 1-2 d 2
-
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
Sablin, Marie-Paule; Bergh, Jonas; Lu, Yen-Shen; Martínez, Noelia; Cortés Castan, Javier; Schmid, Peter; Im, Seock-Ah (BMC, 2021-01-15) -
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population
Turner, N. C.; Alarcón, E.; Armstrong, A. C.; Philco, M.; López Chuken, Y. A.; Sablin, Marie-Paule; Antunes de Melo Oliveira, Ana Mafalda (Oxford University Press, 2019-05-01)